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1. Introduction
1.1. Synaptosomes — Definition, a bit of history
The synaptosome is the presynaptic part of the nerve ending with, as a rulе, a postsynaptic
membrane in the region of the junction of the pre- and postsynaptic membranes that remains
with the presynapse during homogenization and centrifugation. The presynaptic part of the
synaptosome is a membrane-bound structure with a preserved cytoplasm (synaptoplasm),
synaptic vesicles, mitochondria and some other cellular components. The term synaptosome
was adopted by V.P. Whittaker and coworkers [1]. Together, V.P. Whittaker and C.O. Hebb
first isolated and identified nerve endings in nervous tissue [2].
Subcellular fractionation emerged in the 1930s and 1940s and has since established itself as a
major technique in experimental biology. The first attempts at the fractionation of nervous
tissue were made in the early 1950s. A few years later, the fraction of synaptosomes was
successful, using discontinuous sucrose-density gradient centrifugation [2-4]. After this,
researchers achieved the preparation of the synaptic components, including the synaptic
membranes, synaptoplasm, synaptic vesicles [1, 5, 6] (Figure 1) and membrane junction
complex [7, 8]. These studies were a powerful impetus for investigations into the biochemistry
of synapses and in the development of new methods of synaptic fractionation. Synaptosomes,
as nerve endings, are heterogeneous in density, size and mediator specificity. Therefore, a
number of the methods were developed for separating the synaptosomal fraction into two
fractions [4], as well as into many fractions using a continuous sucrose-density linear gradient
[9-11]. Among the many publications at this time, two books stand out. In the first one, D.J.
Jones recounts the story of subcellular fractionation techniques, and presents the entire set of
© 2014 The Author(s). Licensee InTech. This chapter is distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use,
distribution, and reproduction in any medium, provided the original work is properly cited.
modern synaptic and subsynaptic fractionation techniques and data about the ultrastructure
of synaptosomes and synaptic components, their sedimentary characteristics and biomarkers
[12]. In the second one, R.N. Glebov is focused on the achievements of that time in the field of
the functional neurochemistry of synapses, their molecular structure as well as on the metab‐
olism and biochemistry of "classic" neurotransmitters and on the concepts of mediator
secretion [13].
To the left of the tubes are marked the density of sucrose layers (in moles). Fractions obtained from crude mitochond‐
rion fraction (by the method of De Robertis et al., 1962): myelin (A), neuronal and glial membrane and possibly small
synaptosomes (B), light (C) and heavy (D) synaptosomes, cell mitochondria (E). Subsynaptic fractions obtained from
light and heavy synaptosomes fractions (by the method of Whittaker et al., 1964): synaptoplasm (Sp), synaptic vesicles
(1), synaptic membranes (2, 3, 4), non-disrupted synaptosomes (5), synaptic mitochondria (6).
Figure 1. Scheme of distribution of the fractions and subfractions of synaptosomes in discontinuous sucrose-density
gradients.
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2. Synaptosomes as an object of study in vitro and in vivo
Since these techniques were developed, new technologies in brain research have emerged.
However, synaptosomes and their components remain a unique object of study. The reasons
for this are as follows:
• the synapse is a unique structure specialized in the chemical transmission of nerve signals
(chemical synapses are mainly in the mammalian brain).
• the synapse is always at the center of concepts about the adaptive properties of nervous
tissue, such as learning and memory.
• the synapse is the most dynamic and labile structure of the nerve cell, and is an indicator of
the reaction of the neuron to external stimuli.
• the synapse is an inherent structure of the neuron only.
It is now known that neurotransmitters and their key metabolic enzymes exist in some non-
neuronal mammalian and human cells, including some cells of the neuroglia and vascular
endothelium, epithelium and blood. In these cells, neurotransmitters perform specialized
functions such as proliferation, differentiation, migration, organization of the cytoskeleton,
cell-cell contact, secretion and transport of ions and water, blood-brain barrier maintenance
and anti-inflammatory functions [14-17]. So, synaptomoses are the only object of molecular
and biochemical studies that guarantees the investigation of neuronal function. Therefore, new
technologies for the isolation of synaptosomes and their components continue to be developed,
consistent with the purpose of science [18-20].
Using synaptosomes, one may study in vitro the molecular mechanisms of neurotransmitter
secretion and the metabolism of neurotransmitter systems using the entire complexity of the
molecular processes or using models of functional or pathological conditions in vitro and ex
vivo.
Studies on synaptosomes in vivo are rarer but they are not less important. The brain is a very
complicated organ in which a neuron exists in a permanent relationship with many other
neurons. These interactions occur mainly through synapses. It is important not to forget about
the signaling molecules that come into the brain through the blood, cerebrospinal fluid and
intracellular matrix. The functional response of presynapses reflects the integrated response
of the neuron to a stimulus. Therefore, it is important to know whether the patterns of synaptic
functions are identical in vitro and in vivo.
In vivo models are used to investigate effects on the entire organism such as learning models
and models of adapting and neuropathology. Then, the synaptosomes or subsynaptic com‐
ponents from the brain structures can be isolated. It is usually impossible to analyze the totality
of the synaptic molecular and metabolic processes in these studies. The synaptic reaction is
measured by the synaptic key indicators identified in studies in vitro. It is important that the
biochemical methods allow the estimation of very fine metabolic and functional changes in
synapses. The connection between nervous system function and synaptic processes has been
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investigated this way. It is possible to research the reaction of certain brain structures and even
certain neuronal populations to external influences. Using neuromediators as markers, one
can identify the participation of neuromediator systems in the mechanisms of various brain
functions.
Furthermore, the in vivo study of synaptosomes has additional scope. Using biochemical
parameters, not only metabolic changes can be evaluated, but also quantitative (synaptogen‐
esis, reduction, degeneration) and morpho-structural (transformation) reorganizations in the
synaptic pool. This is possible in comparative studies on the synaptic membrane and synap‐
toplasm subfractions. Subfractions of synaptic membranes and the synaptoplasm are the
largest integral parts of the presynapse. Therefore, a correlation between the biochemical
membrane (m) and cytosolic (c) biochemical parameters may reflect the reaction of the
presynapse as a structural unit.
3. Natural markers of the neuronal systems
Neurotransmitters and some molecules of neurotransmitter metabolism are used as neuronal
markers. These are natural indicators of functionally specialized brain systems, given to us by
nature. Therefore, neuronal markers are widely used in biochemical studies, both in vitro and
in vivo.
Neurotransmitter systems are named based on the main transmitter (glutamatergic, GABAer‐
gic, dopaminergic, etc.). Each mediator system consists of several neuronal populations. The
neuronal populations in the brain are distributed topographically. Depending on the locus in
the brain, neurons form specific neuronal connections using a specific combination of recep‐
tors. Moreover, these neurons can have specific metabolism dependent on their functional
destination. Therefore, topography determines their metabolic and functional effects. Addi‐
tionally, different neuronal populations often express comediators. These comediators
influence the effects of mediators and metabolic pathways of the neuron in certain ways. It
seems that future prospects in the study of brain function will be the investigation of the
functional, metabolic and molecular features of distinct neuronal populations. It is necessary
to understand the true mechanisms of the regulation, maintenance and recovery of brain
functions. It should be noted that studies on synaptic fraction levels were carried out along
these lines from the beginning [4, 18, 21-31].
In particular, regarding the cholinergic brain system, studies on this neurotransmitter system
have been performed on synaptic fractions in vitro and in vivo. This review will present data
from investigations into the molecular properties and metabolic and functional characteristics
of cytosolic (c) and membrane-bound (m) choline acetyltransferase (ChAT) and of the use of
cChAT and mChAT as cholinergic markers to establish brain function mechanisms. For the
sake of completeness regarding modern notion, the characteristics of the molecular forms of
ChAT will be presented using data from tissue cultures as well.
But first, a brief description of the cholinergic brain system.
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4. Cholinergic brain system, cholinergic neuronal populations and their
importance in health and disease
Cholinergic neurons use the classical neurotransmitter acetylcholine (ACh). ACh is a famous
mediator. It was the first neurotransmitter discovered, by Otto Loewy in 1921-1926, and it
proved the validity of the chemical nature of nervous communication [32]. ACh was quantified
in P. Fatt’s and B. Katz’s experiments when the quantum nature of chemical neurotransmission
was discovered [33]. S.O. Hebb and V.P. Whittaker used ACh and ChAT as indicators when
they searched for and found subneuronal structures (synaptosomes) which accumulate
mediators [2]. ACh was the first among the neuromediators found in the non-neuronal cells
of mammals [34]. It would perhaps be helpful to add that ACh is also called "gentleman number
one", for its non-neuronal function as well. It is clear that ACh is the most thoroughly examined
neurotransmitter.
4.1. Metabolism of acetylcholine
ACh is an ester of acetic acid and choline with the chemical formula CH3COO(CH2)2N+
(CH3)3 and systematic name 2-acetoxy-N,N,N-trimethylethanaminium.The cycle of ACh
synthesis, storage, release and degradation has been well-characterized at the cellular and
molecular levels [26, 35, 36]. Briefly (Figure 2), ACh is synthesized in the cytoplasm of
cholinergic neurons from the precursors choline and acetyl-coenzyme A by the enzyme choline
acetyltransferase (ChAT), and is then taken up into synaptic vesicles for storage by the
vesicular acetylcholine transporter (VAChT). Depolarization of the nerve terminal causes the
fusion of synaptic vesicles with the presynaptic membrane at specialized release sites called
active zones (named the junction complex in the subsynaptic fraction). Depositing and
releasing ACh is a calcium-dependent process that involves the coordinated actions of many
presynaptic proteins [26, 37]. When vesicles are linked up with the presynaptic membrane,
ACh diffuses into the synaptic cleft where it can bind to subtypes of nicotinic and muscarinic
receptors located on both post- and presynaptic membranes. ACh signaling is terminated by
its diffusion away from the synaptic cleft and by its rapid hydrolysis into choline and acetate
by acetylcholinesterase (AChE). The choline derived from ACh hydrolysis is recycled into the
presynaptic terminal by the sodium-dependent high-affinity choline transporter (CHT) for
resynthesis of ACh. After secretion of ACh, synaptic vesicles are recycled and are refilled with
the neurotransmitter for another round of the depolarization-induced release. It should be
noted that the details of the molecular mechanism of the regulation of these processes in both
health and disease are lacking.
4.2. Topography and functions of cholinergic neuronal populations
Knowledge of the topography of mediator systems is basic for neurobiologists. The topogra‐
phy of the populations of cholinergic neurons and their projections has been studied in detail.
ChAT has long been used as a marker of cholinergic structures in immunohistochemical
studies. Initially, AChE was used as the cholinergic marker, but it was found that AChE
coincides with ChAT only partially [38]. Later, colocalization of AChE was revealed in non-
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cholinergic neurons. For example, 36% of AChE-positive cells are GABA-immunoreactive [39].
VAChT, discovered after ChAT, is also used as a marker [40]. However, some discrepancies
between VAChT and ChAT have been found [41].
Cholinergic neurons innervate almost all areas of the nervous system, both the central and
peripheral systems. These areas can be innervated by either extrinsic projective neurons or by
intrinsic interneurons. A very famous and major group of cholinergic projective neurons is
found in the basal forebrain, which is comprised the nucleus basalis magnocellularis, also
called the Meynert nucleus in primates and humans (a large bundle of cholinergic neurons
encompassing the magnocellular preoptic nucleus, substantia innominata and globus pal‐
lidus), the medial septal nucleus and the vertical limb nucleus of the diagonal band of Broca.
The idea of the scheme is taken from Black and Rylett [Black & Rylett, 2011]. Abbreviations: Presynapse, presynaptic
part of nerve ending; SV, synaptic vesicle; ACh, acetylcholine; AcetylCo-A, acetylCoenzyme-A; cChAT and mChAT, cyto‐
plasmic and membrane-bound choline acetyltransferase correspondingly; mAChE and cAChE, membrane-bound (ex‐
tracellular isoform) and cytoplasmic acetylcholinesterase correspondingly; CHT, sodium-dependent, high-affinity
choline transporter; M, muscarinic receptor; N, nicotinic receptor; VAChT, vesicular ACh transporter.
Some details of molecular mechanisms of the regulation of these processes are set out in sub-chapter 4.1.
Figure 2. Mechanisms involved in the synthesis, storage, release and degradation of ACh at the cholinergic synapse.
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The cortex, amygdaloid complex, hippocampus and olfactory bulb receive their cholinergic
innervation principally from cholinergic projection neurons of the basal forebrain [40-49]. It is
known that basal forebrain cholinergic projective neurons play a role in attention, learning,
memory and consciousness. Another group of cholinergic projective neurons is found in the
upper brainstem, which is comprised the pedunculopontine nucleus of the pontomesence‐
phalic reticular formation and within the laterodorsal tegmental gray of the periventricular
area. The thalamus and medulla receive their cholinergic innervation principally from
cholinergic projection neurons of these brainstem nuclei. These neurons also present a minor
component of the corticopetal cholinergic innervation of the frontal and visual cortical areas
[43, 49-51]. The cholinergic projective neurons of the mesopontine region play a role in the
primary treatment of some sensory information and memory (in the thalamus) and, hypo‐
thetically, in the central mechanisms regulating respiration and blood circulation (in the
medulla). All immunohistochemical studies indicate the topographical arrangement of
cholinergic projections. On the basis of connectivity patterns, M.M. Mesulam and coworkers
proposed that the central cholinergic projective neurons to subdivide into six major sectors
designated Ch1-Ch6 [43]. Moreover, the rostrocaudal and layerwise topographical arrange‐
ment of the cholinergic projections is indicated in the cerebral cortex [44-46, 48].
The most famous cholinergic interneurons are localized in the striatum, and they are involved
in motor function and cognition [49]. As well, cholinergic interneurons have been detected in
the cerebral cortex [46, 48, 52] and in the hippocampus [53-55]. Cortical and hippocampal
interneurons perform associative functions and are presumably involved in learning and
memory. Numerous electrophysiological studies have indicated this, but regarding choliner‐
gic cortical and hippocampal neurons, such data are absent. In the human cerebral cortex,
ChAT-immunoreactivity was found in some of the giant Betz and Meynert's pyramidal
neurons [56].Cortical pyramidal neurons carry out motor functions. The medullar reticular
formation has ChAT-positive neurons and their participation in the respiratory center is
assumed [50].
Finally, ACh as a neurotransmitter is widely presented in the peripheral nerve system [40, 49,
57]. Acetylcholine is one of many neurotransmitters in the autonomic nervous system and is
the only neurotransmitter used in the motor division of the somatic nervous system. The
parasympathetic motoneurons of as the cranial nuclei of the caudal brainstem and postgan‐
glionic neurons and preganglionic sympathetic motoneurons of the spinal cord nuclei are
ChAT- and VAChT-positive. Their efferents innervate all vegetative organs and glands,
parasympathetic directly and sympathetic indirectly. ChAT- and VAChT-immunoreactivity
has also been detected in the cell bodies of the spinal nerve motor neurons as well as in their
axons and the endplates of the skeletal muscles.
It was found recently that the vagus (parasympathetic) nerve, involved in the control of heart
rate, bronchomotor tone, hormone secretion and gastrointestinal motility, is also an immuno‐
modulator. Its stimulation attenuates the production of proinflammatory cytokines and
inhibits the inflammatory process via the α7 nicotinic acetylcholine receptor [58, 59]. It is
possible that these studies are beginning to describe a new function of the cholinergic nerve
system.
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4.3. Comediators and other neuroactive components in some cholinergic neuronal
populations
The functional effects of ACh are unique to each cholinergic population due to its targets and
chemical composition. As a whole, ACh functions more often as a modulator in the central
nervous system and as a mediator in the peripheral nervous system. Some populations of
cholinergic neurons co-express vasoactive intestinal peptide (VIP) or/and nitric oxide (NO) or
substance P. VIP has been found in cholinergic interneurons of the cortex [48, 60, 61] and in
the parasympathetic efferents to the airways [62, 63]. Substance P is present in the majority of
projections to the medial frontal cortex from ChAT-positive neurons in the midbrain [48].
ChAT-VIP-, NO synthase-ChAT- and NO synthase-ChAT-VIP-immunoreactive ganglionic
cells have been detected in the sphenopalatine ganglia [64, 65].
All three substances as well as ACh are well-known vasodilators. Therefore, their co-localiza‐
tion with ACh is connected in the first place with blood flow regulation. The vasodilator action
of ACh on the vessels of the vegetative organs was one of its first described effects [66]. With
respect to cerebral vessels, it was detected in (1) direct contacts with small cortical vessels with
vasodilator effects of the cholinergic projective neurons and interneurons, including ACh-VIP-
containing interneurons [61, 67-69]; (2) ACh-, NO-ACh- and rarely ACh-VIP- containing fibers
innervate the middle cerebral arteries composed of perivascular nerves of the sphenopalatine
ganglia [64]; (3) ACh induces both direct vasodilation and atypical constriction in the internal
cerebral arteries [64, 70, 71]; (4) brainstem ACh indirectly induces, via the stimulation of the
dorsal facial area neurons of the medulla, a vasodilator effect in the common carotid and the
internal cerebral arteries [72, 73].
The third vesicular glutamate transporter (VGLUT3) is present in a subset of cholinergic
projective neurons in the basal forebrain and in cholinergic interneurons in the striatum [74].
It should be noted that both these cholinergic populations have similar large neurons. VGLUT3
is one of three transporter isoforms that fills synaptic vesicles with glutamate; however,
VGLUT3 is also expressed in neurons and brain regions that were not previously thought to
use glutamate as a neurotransmitter. It is possible that VGLUT3, because of its ionic balance,
helps to load synaptic vesicles with ACh. In addition, the cholinergic projective neurons of the
basal forebrain express the nerve growth factor (NGF) receptor [75, 76]. Basal forebrain neurons
are trophically responsive to NGF. Neurotrophin is important for the development and
maintenance of the basal forebrain cholinergic phenotype. In these neurons, NGF markedly
increases ACh synthesis, content and release [77, 78].
4.4. Cholinergic functions and brain diseases
The brain cholinergic system is of permanent interest for neuroscientists because of its
important role in cognitive, attention and motor functions. Dysfunction of cholinergic
neurotransmission in the central nervous system is revealed in a number of neurological
disorders. Dysfunction and degeneration of the cortical and hippocampal cholinergic projec‐
tions from the basal forebrain nuclei is the basis of the pathogenesis of diseases such as
Alzheimer's disease and Lewy body dementia, as well as diseases with other etiologies such
as schizophrenia, Parkinson's disease and cerebral ischemia, in some cases aggravated by
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cognitive impairment [79-88]. The leading role of cholinergic afferent dysfunction in the
development of ischemic pathology was suggested by data on the sensitivity of cortical and
hippocampal cholinergic projections to ischemic exposure and a correlation between the
development of cholinergic dysfunction, the delayed death of pyramidal neurons and
cognitive impairments in rodents [89-91]. Dysfunction of cholinergic interneurons of the
striatum is partly responsible for involuntary movements in Harrington's disease [80, 92]. Low
expression of ChAT in the cholinergic neurons of the motor nuclei of the spinal cord is a specific
early sign of amyotrophic lateral sclerosis [80, 92]. Multiple abnormalities in cholinergic
function in the motor nuclei of the spinal cord a responsible for congenital myasthenic
syndrome [93].
4.4.1. Synaptic soluble and membrane-bound choline acetyltransferase and their participation in
cholinergic function in vitro and in vivo
Choline acetyltransferase (ChAT, E.C. 2.3.1.6) is a key enzyme in ACh synthesis and a marker
of cholinergic neurons. It catalyzes the transfer of an acetyl group from acetyl-CoA to choline
to form ACh. Studies in recent decades have revealed (1) the significant role of ChAT in the
regulation of ACh synthesis and secretion and (2) that disturbances in the catalytic properties
of ChAT may be the origin of some neuropathologies.
5. Forms of ChAT
It has been shown that ChAT has both a hydrophilic (cChAT) and hydrophobic state (station‐
ary mChAT) in nerve endings. It has also been shown that ChAT is able to translocate from
the cytosol to the synaptic membrane and to turn reversibly into the hydrophobic state
associated with the synaptic membrane by ionic links (ionic-bound mChAT) [92, 94-96]. All
this presupposes the existence of multiple forms or isoforms of the enzyme. Also, differences
in the optimum pH, substrate specificity, sensitivity to the selective inhibitor 4-(1-naphthyl)
pyridine (NVP) and some other molecular characteristics of the synaptoplasm and synaptic
membrane fractions indicated this [97-99].
Research has revealed only one ChAT gene that encodes the multiple forms and isoforms of
the enzyme [80, 83]. High homology has been detected between ChAT gene nucleotide
sequences in the mouse, rat, pig and human brains with differences in the 5'-noncoding region.
Polymorphisms of ChAT mRNAs are due to alternate splicing and various use of at least of
five non-coding exons in the promoter region of the gene [100].
Five types of mRNA have been isolated from the rat brain ChAT (R1/2-, N1/2- transcripts and
M-) [101] and six types from the human brain (R1/2-, N1/2-, S- and M-transcripts) [83]. All five
ChAT transcripts generate ChAT with a molecular weight of 69 kDa (ChAT-69). This is the
major form of ChAT in the CNS. In addition, the human M and S transcripts generate minor
forms of ChAT with a molecular weight of 82-83 kDa (ChAT-82) and 74 kDa (ChAT-74) [80,
83, 93, 100, 102, 103]. Also, ChAT-69 and ChAT-82 are subdivided into a number of isoforms
with differences in the isoelectric point [104].
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The cytoplasm and plasma membranes of cholinergic neurons express only ChAT-69 [80, 83,
100]. In the human brain, ChAT is also found in the cell nucleus. Initially, ChAT-82 was
selectively found in the nucleus in some brain structures [82, 95, 104, 105] and, later, ChAT-69
was also found [83]. In rat ganglia in the central nervous system at the level of the medulla
oblongata, ChAT is expressed with a molecular mass of about 50 kDa and is called peripheral
ChAT (pChAT). pChAT also exhibits alternative splicing of the mRNA [106].
The physiological significance of such a large number of isoforms of ChAT is not clear at
present.  Also,  the  relationship  between  of  ChAT-69  isoforms  in  subsynaptic  compart‐
ments is not known. Polymorphisms in ChAT transcripts suggest that ChAT isoforms or
transcripts  may  vary  in  stability  or  translation  efficiency  or  may  be  differentially  ex‐
pressed in  response to  trophic  or  pathological  factors.  Thus pChAT is  not  expressed in
cholinergic neurons of the parasympathetic dorsal motor nucleus of the vagus nerve and
nucleus ambiguus in the medulla of intact rats but pChAT- positive neurons were detected
in these nuclei after axotomy against the background of almost disappearance of ChAT-69-
positive neurons [107]. Furthermore, targeting of the enzyme to the cell nucleus suggests
that  ChAT  may  be  able  to  perform  other  functions  in  addition  to  its  essential  role  of
synthesizing ACh in nerve terminals [102].
6. Features of ChAT phosphorylation
It is known that the genome does not provide the variety in the protein forms presented in a
cell. In this regard, the post-genomic protein modifications are of special significance. Phos‐
phorylation is one of the most studied pathways of the post-translational influence on the
molecular properties of enzymes. Covalent modifications to serine, threonine and tyrosine
residues in protein molecules can dynamically change their physicochemical nature, as well
as regulate protein function and interactions with cellular components. This has been shown
for the key enzyme in the synthesis of dopamine (tyrosine hydroxylase) and serotonin
(tryptophan hydroxylase) and for glutamate decarboxylases GAD65 and GAD67, two
synthetic enzymes of gamma-aminobutyric acid (GABA) [108].
For a long time, ChAT was not related to rate-limiting enzymes on the basis of kinetic
calculations. It was believed that the ChAT synthesis rate dependents only on fluctuations in
the levels of the substrate and the product of the synthesis, although ChAT is not saturated by
choline and acetyl-CoA in their physiological concentrations [35]. However, in recent decades,
other intracellular factors have been revealed to regulate the activity of the enzyme. These data
suggest an important regulatory role of ChAT in the synthesis and secretion of ACh [36, 82,
103, 108, 109]. It is assumed that the cause of several diseases is spontaneous point mutations
in the molecule of ChAT or of its regulatory proteins which lead to dysregulation of the enzyme
or to changes in its ability to communicate with regulatory factors [93, 108].
As a rule, the different effects of phosphorylation on synaptic soluble (hydrophilic) cChAT
and membrane-bound (hydrophobic) mChAT occur even with non-specific stimulation by the
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substrates ATP or phosphorus (Pi). Increased ATP markedly affects the specific activity of
mChAT compared with cChAT [37]. At rest, cChAT but not mChAT is phosphorylated in
incubation medium enriched with Pi. Under these incubation conditions, veratridine depola‐
rization selectively activated and dephosphorylated mChAT but had no influence on either
the degree of phosphorylation nor the activity of cChAT. Removal of Ca2+ from the incubation
medium significantly inhibited the phosphorylation of cChAT and the specific activity of
mChAT [110].
It has been shown that, in vivo, ChAT exists as a phosphoprotein [36, 111]. In vitro, phosphatase
inhibitors activate cChAT and mChAT a little, even under non-phosphorylation conditions
(ATP absent in the incubation medium) [37]. ChAT is a substrate for certain protein kinases.
The amino acid sequence of the enzyme suggests the existence of multiple sites for phosphor‐
ylation by protein kinases such as protein kinase C (PKC), α-Ca2+/calmodulin-dependent
protein kinase II (CaM2), casein kinase II (CK2) and some others [108]. ChAT-69 is phosphory‐
lated by the serine/threonine kinases CK2, PKC and CaM2 [92, 95, 105, 112].
It should be noted that PKC and CaM2 are the well-known and important regulators of
neuronal functions. CaM2 is an obligatory component of the cholinergic vesicular mechanism
[37], and PKC plays an important role in the regulation of ChAT molecular properties [36].
The authors also make the conjecture that oxidative stress can alter the phosphorylation-
dependent regulation of ChAT expression and ACh synthesis in the aging brain and in the
early stages of vascular and Alzheimer’s disease and related disorders. Both of these protein
kinases interact with serine/threonine residues which the protein kinases use for ChAT
phosphorylation [92, 95, 108, 112]. In different studies, PKC activated cChAT and mChAT with
variable efficacy [37, 95, 104]. It has been shown that different protein kinase isoforms have
distinct patterns and ChAT phosphorylation by PKC isoforms has a hierarchical construct [92,
95, 108, 112]. Thus, phosphorylation of Ser-476 had no effect on the molecular properties of
ChAT but allows the possibility of phosphorylating other serine residues, such as Ser-440 and/
or Ser-346/347 which are necessary to maintain the catalytic activity of ChAT under basal and
stimulated conditions. Also, Ser-346/347 modulates ChAT phosphorylation at other amino
acid residues, and Ser-440 initiates the translocation of soluble ChAT to the cellular membrane
and the formation of ionic-bound ChAT.
CaM2 and its inhibitors selectively regulate mChAT activity without affecting the activity of
cChAT [37]. These data were also confirmed indirectly by experiments with total ChAT
(actually cChAT), in which CaM2 phosphorylated but did not activate the enzyme [104].
Further investigations showed that CaM2 activated total ChAT in terms of the combined
phosphorylation of Thr-456 by CaM2 and of Ser-440 by PKC [112]. It is assumed that this PKC
feature of the potentiation of CaM2 action in cholinergic projection neurons of the hippocam‐
pus and the cortex is dramatically implicated in the pathogenesis of Alzheimer's disease [112].
Likewise, PKC inactivation of Ser-440 phosphorylation is implicated in the pathogenesis of
myasthenic syndrome in the motor nuclei of the spinal cord [94, 113].
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7. Role of cChAT and mChAT in regulation of acetylcholine synthesis and
secretion – In vitro studies
In neurons, the principal place of synthesis of ACh is in the nerve endings. ChAT has long
been recognized as a cytoplasmic enzyme, even after its detection on synaptic membranes in
the 1960s [1, 114]. Later, it was shown that ChAT exists as a structural membrane protein [95,
115-117]. The long-term study of the properties of synaptic soluble (c) and membrane-bound
(m) ChAT in vitro has shown that the relationship between ChAT activity and the secretion
of ACh depends on the compartmentalization of the enzyme.
7.1. Functional properties of synaptic cChAT
Soluble cChAT activity is the prevalent activity of synaptic ChAT. cChAT regulates the
dynamic equilibrium between the synthesis and degradation of ACh in the resting state [35,
99, 118, 119]. Under physiological conditions, cChAT is activated during stimulation by
depolarizing agents such as K+ and/or veratridine [37, 120, 121]. Another regulator of the level
of free cytosolic ACh is AChE, the enzyme that mediates ACh splitting. A close interaction
takes place between cChAT and soluble cAChE [120]. Thus, in calcium-free medium condi‐
tions, the quantum release of ACh is blocked, the activity of cChAT is not changed and cAChE
is activated and cleaves an abundance of ACh [120, 122].
From these experiments, it follows that non-quantum, Ca2+-independent "leak" of acetylcholine
and its decay products, choline and acetate, is in direct dependence on the ratio of the activity
of these two cytosolic enzymes [120, 122, 123]. In these studies, (1) K+ stimulation in calcium-
free medium causes the release of cytosolic choline due to disruption of cytosolic ACh by
cAChE and (2) veratridine stimulation can cause the release of both choline and cytosolic ACh.
(3) In mAChE and cAChE inhibition conditions by a tertiary inhibitor such as paraoxon coming
through the plasma membrane, the release of choline is blocked under veratridine stimulation
in calcium-free medium and its extracellular level is decreased. Instead of choline, the release
of cytosolic ACh is observed. (4) Under cChAT and mChAT inhibition conditions by the
selective inhibitor NVP, cChAT is selectively activated and the release of newly synthesized
ACh is increased directly from the cytosol under veratridine stimulation in physiological
medium (in the presence of Ca2+). (5) A similar output of ACh is observed under the same
conditions in calcium-free medium.
The choline and ACh concentrations could increase by 40-60% in the extracellular medium in
such a non-quantum manner. Choline is a selective agonist of α-7 subtype of ACh nicotinic
receptors [65, 124]. Thus, the "leak" of cytosolic choline and/or ACh, as well as changes in their
relationship in the extracellular environment may have independent signaling effects in
intercellular interactions.
7.2. Functional properties of synaptic mChAT
The functional purpose of mChAT has long been unclear [80, 125]. Investigation of this
problem was difficult in the absence of selective inhibitors of cChAT and mChAT. Their
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separation is possible only by subsynaptic fractionation in combination with methods that
destroy the synaptosome. The contribution of mChAT to general ChAT activity is low, i.e.
4-15% [1, 94, 95, 97, 119]. Therefore, for a long time, it was assumed that the association of
ChAT with neuronal membranes was an artifact as the result of synaptoplasm contamination
[1, 35, 114].It has now been shown that mChAT exists (1) as stationary membrane protein [99,
115, 117] and (2) as ionic-bound mChAT, a reversible form of cytosolic ChAT [95, 126].
In vitro, mChAT like cChAT are activated in response to K+ or veratridine stimulation in
physiological medium [37, 110, 120, 121]. Compelling data have accumulated regarding the
direct involvement of mChAT in the mechanisms of quantum secretion of acetylcholine. This
is indicated by a number of ultrastructural and functional characteristics of the enzyme.
mChAT is localized to synaptic vesicles [127]. Its activity, unlike cChAT, depends on the
specific factors of ACh transfer into the vesicles, VAChT and the proton gradient, and on CaM2
activity, which is the main kinase associated with synaptic vesicles [37]. Activation and
inhibition of mChAT are fully coupled with the activation or, respectively, blockade of ACh
quantum release [120].
The non-vesicular Ca2+-dependent pathway of the quantum secretion of ACh has been revealed
[128-131]. It was shown that this pathway provides fast secretion of ACh by a synaptic
membrane structural protein [132] called mediatophore [128]. It was found that mediatophore
is functional linked to ChAT [133]. This suggests that mChAT located on the synaptic mem‐
brane participates in the regulation of the quantum secretion of ACh, similar to vesicular
mChAT. This agrees with the preferential sensitivity of mChAT to the functional state of CHT
that is selectively localized to the neuronal membrane of cholinergic neurons [94, 134].
mChAT is selectively sensitive to the balance of ions. It is known that ions are important
regulators of quantum neurotransmitter release and other transmembrane functions. Control
of quantum ACh release is carried out by the interaction of the Ca2+ and H+ balance (vesicular
Ca2+/H+ antiporter), Zn2+ and K+ (K+ channels) [131, 135-138]. mChAT activity is selectively or
preferably (1) inhibited in calcium-free medium [118, 120, 121], (2) is increased at a high
concentration of Ca2+ and/or K+ [37, 110, 121, 123, 139], (3) is dose-dependently inhibited by the
intracellular concentration of Cl - [118, 125] and increases in conditions of a high Cl - concen‐
tration and chloride conductivity stimulation [125]. (5) Zn2+ regulates both pathways of the
quantum secretion of ACh. High concentrations of Zn2+ block ACh release from vesicles and
through mediatophore [135, 140]. Similarly, the direction of ChAT translocation depends on
Zn2+ ions. Zn2+ blocks the "anchoring" of ChAT on the membrane [126]. The last argument
indicates the involvement of ionic-bound mChAT in the quantum release of ACh.
So, the catalytic properties of cChAT and mChAT depend on phosphorylation and possibly
on the type of splicing. Moreover, the specific activity of mChAT, unlike cChAT, also depends
on the ionic environment and on other factors affecting the quantum secretion of ACh. The
functional significance of mChAT is not nearly as clear as cChAT. The relationship between
cChAT and mChAT and their dependence on external influences are poorly understood [138].
Nevertheless, it seems that the compartmentalization of the enzyme ensures the involvement
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of cChAT and mChAT in different functional-metabolic cycles, which may contribute to the
fine regulation of the mediator actions of ACh.
8. cChAT and mChAT as markers of functional and structural
reorganization in cholinergic nerve endings following external exposure
— In vivo studies
The synaptosomal subfractions of the synaptic membranes and synaptoplasm of the cortex,
hippocampus and some other rat brain structures are used for research in vivo cholinergic
mechanisms of brain functions by biochemical methods (radiometric and spectrophotometric).
Subsynaptic fractions gave according to the scheme shown in Figure 1. Respectively, mChAT
and cChAT activity and the m-protein and c-protein content have been measured to estimate
cholinergic function. In addition, in some experiments, mAChE and cAChE and Na+/K+-
ATPase activity was measured. The Na+/K+-ATPase activity and content of synaptic proteins,
as universal synaptic parameters, as well AChE activity were correlated with ChAT activity
in those cases when the cholinergic reaction following exposure was dominant in the synap‐
tosomal fraction. Generally, models of acute (3 hours) and chronic (11-14 days) brain ischemia
(bilateral occlusion of the carotid arteries, the 2VO model) or acute hypobaric hypoxia with
variable intensity (10% O2, 60 min; 6.5% O2, 15 min; 4.5% O2, 1-3 minutes or 10-20 minutes)
were used as the exposure methods.
8.1. Biochemical equivalents of activation and inhibition of cholinergic mediator function
In in vivo investigations, ChAT activity was found to be the most mobile parameter. So, ChAT
has become the main landmark for analysis of the cholinergic reaction to exposure.
cChAT activation was observed under acute ischemia or hypoxia at all intensities [27, 29,
141]. mChAT or both mChAT and cChAT activation was revealed under acute and chronic
ischemia and only in severe hypoxia (4.5% O2) [27-29, 141]. When the activation of ChAT was
observed (165-170%), extracellular mAChE (the predominant isoform of mAChE) was
simultaneously activated [141]. cChAT activation positively correlated with the activation of
Na+/K+-ATPase and negatively correlated with the decrease in the c-protein content [27]. All
these reactions of the synaptic biochemical parameters and their combinations are regarded
as the activation of cholinergic synaptic function, because they conform to the characteristics
of synaptic activation.
Compared to cChAT, the selective activation of mChAT has been revealed (1) under equal
experimental conditions (3 hours of ischemia) in rats less resistant to hypoxia [141], and (2)
under hypoxic conditions with variable intensity only in severe hypoxia [27] and was not
observed in the subcritical and moderate hypoxia (6.5% or 10% O2) [27, 29]. A parallel study
of the ultrastructure of the synapses in the cortex revealed the dependence of swelling synapses
and synaptic mitochondria on the duration of severe hypoxia [27]. Taken together, these data
suggest that the activation of mChAT in vivo occurs due to an imbalance of synaptic Ca2+,
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while cChAT activation is apparently initiated in the natural physiological way, under
neuronal influences [27].
The inhibitory reactions of ChAT under ischemic/hypoxic conditions were revealed as well. It
was found that these conditions decrease cChAT or mChAT or both cChAT and mChAT
activity [27-29, 141]. Also, a negative correlation has been found between cChAT activity and
the c-protein content and a positive correlation has been found between mChAT activity and
the m-protein content [27, 29, 141].
A parallel study of the ultrastructure of the synapses in the cortex revealed a significant
decrease in the number of vesicles docked to the presynaptic active zone in the rat with a
profound decrease in both cChAT and mChAT activity in acute hypoxia [27, 142].Taken
together, these data suggest that such a decrease in ChAT activity in vivo may reflect the deep
inhibition of cholinergic synaptic function as result of the superexcitation, the equivalent of
the well-known "depression of neurons" in electrophysiology, i.e. reduced neuronal excitabil‐
ity due to the depletion of mediator substrates.
Selective inhibition of mChAT, as well as its activation, is likely a consequence of a disturbance
in the ion balance. Based on the dominance of the hypoxic factors in these experiments, it is
supposed that the decrease in mChAT activity is due to the accumulation of H+ ions in the
presynapses [27, 29]. It can be induced (1) by acidosis in the case of severe hypoxia and (2) by
the weak increase in H+ ion concentrations as the primary response to hypoxia in the case of
moderate hypoxia (10% O2). It has been shown that such primary H+ ion accumulation is
subthreshold for the initiation of cellular acidosis and can disrupt the function of the Ca2+/H+
antiporter [143].
Finally, cAChE activation has been detected under acute ischemia [141]. This is probably
another means of regulating the abundance of free cytosolic ACh during the inhibition of ACh
quantum transmission. The simultaneous increase in the c-protein content in the same
synaptosomal fraction corroborates this supposition. It is well-known that numerous fibrillar
synaptic proteins are soluble at rest and quickly form a structure under stimulation conditions.
So, the high reactivity as cChAT and mChAT and the peculiarities in the manifestation of ChAT
(and AChE) activity according to the compartmentalization of the enzyme and to the experi‐
mental situation in vivo testify to the naturalness of functional properties cChAT and mChAT
(and also c- and mAChE) revealed in vitro.
8.2. Biochemical equivalents of the quantitative changes in the cholinergic synaptic pool
The correlations in the activation or inhibition of cChAT and mChAT may reflect changes in
a number of cholinergic synapses, namely synaptogenesis (the growth of new synapses) or
their elimination, retraction or another means of reduction in the quantity of nerve endings.
As was described above, the correlation between the biochemical synaptic membrane and
cytosolic parameters may reflect the reaction of the presynapse as a structural unit. The most
reliable criterion of the quantitative reorganization of cholinergic synapses is the positive
correlation between ChAT activity and the c-protein content, since their functional changes
have contrasting directionality.
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A reduction in the number of presynapses was provoked by acute hypoxia of variable severity
[27, 29]. It was shown by various methods, including non-invasive video technology, that a
reduction in the number of synapses can occur within minutes or tens of minutes [144-148].
Sprouting as well as destruction with the swelling of neurons and their terminals, including
cholinergic neurons, predominates in late brain ischemia or postischemic reoxygenation (over
days and months) [149-152]. In biochemical studies, the activation of ChAT was observed in
the majority of the synaptic subfractions of the cortex and hippocampus following chronic
brain ischemia [28]. The correlated increase between mChAT activity and m-protein content
could indicate synaptogenesis and hyperfunction of the cholinergic synapses, whereas the
correlated increase between cChAT/mChAT activity and the c-protein content indicates
synaptogenesis only.
8.3. Biochemical equivalents of the morpho- structural reorganization in the cholinergic
synaptic pool
Under the influence of moderate hypoxia (10% of O2, 60 min), an increase in the activity of
cChAT and the c-protein content was observed in the “light” synaptosomes from the caudal
structures of the brainstem [29]. This indicated an increase in quantity of the corresponding
synapses; however, synaptogenesis was impossible in such a brief period. Additional analysis
revealed a decrease in the activity of mChAT and the m-protein content in the "heavy"
synaptosomal fraction of the same brain structures. This decrease in the “m” biochemical
parameters in the "heavy" fraction negatively correlated with the increase in the corresponding
“c” biochemical parameters in the "light" fraction.These data indicate the transformation of
presynapses from one morphological type to another.
This phenomenon of the transformation of synapses was found in electron microscopic
experiments during 90 minutes of severe hypoxia [144, 145]. It was shown that the change of
a morphological type occurs due to the changes in the area, density and configuration of the
network elements of the presynapses and in their configuration [153]. Almost all of these
parameters can affect the density of the presynapses. Therefore, it is possible that some
population of the cholinergic presynapses from the "heavy" synaptosomal fraction trans‐
formed into presynapses with the less density and was located in the “light" fraction of the
sucrose density gradient. Apparently, this transformation resulted in a morphological type
more resistant to hypoxia.
In such studies on synaptic subfractions in vivo, various cholinergic synaptic reactions have
been revealed in response to hypoxic/ischemic exposures. The responsiveness of synaptic
cChAT and mChAT allows the study of synaptic reactions depending on the exposure
conditions, the functional specificity of different brain structures and neuronal populations. It
was noticed that a reaction to the hypoxia had phase type of change in the course of intensi‐
fication of hypoxic exposure [27]. As well a diversity of the plastic possibilities of the brain is
detected. For example, under the same moderate hypobaric hypoxic conditions (10% O2, 60
min) which initiated an increase in resistance to hypoxia, three alternative cholinergic adaptive
pathways were obtained in the same brain structure (the caudal brainstem) in three different
groups of rats. Transformation and activation of the presynapses was seen in one of the rat
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groups and the inhibition of cholinergic activity in different populations of presynapses (in
the light or heavy synaptosomes) was seen in the other two groups [29]. The mechanisms
behind this plastic diversity are unknown, although it is clear that it is associated with
individual neuronal organization of brain functions.
8.4. Cholinergic organization of brain functions under normal conditions and patterns of
adaptive reorganization under the influence of stress stimuli or pathological conditions
Synaptic ChAT activity can be used as an instrument to study the cholinergic mechanisms of
brain functions in vivo. Biochemical (radiometric) methods to estimate synaptic ChAT activity
are very sensitive and allow for assessing fine individual differences between experimental
animals. In turn, this method allows for successful correlation analysis between ChAT activity
and indicators of brain function and performance. Moreover, it is possible to study certain
populations of cholinergic neurons using, for example, the synaptic fractions of the cortex and
hippocampus.
As mentioned above, according to immunohistochemical data, both the cortex and the
hippocampus have two basic sources of cholinergic innervation. The first major source is
neuronal projections from the forebrain nuclei. The second minor source is interneurons
(intrinsic neurons). The third source to the frontal and visual cortical areas from the meso‐
pontine region is weak and biochemical methods can detect it only when the frontal or visual
area is assessed separately. In these brain structures, ChAT activity was estimated in the
fractions of the light and heavy synaptosomes (isolated as in [4]), and it appeared that these
fractions both in the cortex and in the hippocampus differ in terms of functional activity. From
this, it follows that in both brain structures, the cholinergic presynapses from different sources
are isolated in different synaptosomal fractions during preparation in the sucrose density
gradient.
Next, it was revealed that the ratio of ChAT activity in the light and heavy synaptosomal
fractions corresponded to the ratio of the immunoreactivity of the enzyme in the projections
and interneurons [46, 48, 52, 53, 154].This and some other data promoted the conclusion that,
in the cortex and hippocampus, the presynapses of cholinergic projections from the forebrain
nuclei accumulate mainly in the light synaptosomal fractions, whereas the presynapses of
cholinergic interneurons accumulate mainly in the heavy synaptosomal fractions [27, 27, 155].
This differential approach was used to study rat and cat brain cholinergic synaptic organiza‐
tion of cognitive functions such as learning, different forms of memory and inherited abilities
in some experimental situations. mChAT and cChAT activities of the light and heavy synap‐
tosomes of the hippocampus and/or cortex were used as markers of forebrain projections and
interneurons, respectively. These studies revealed some patterns in the relationship between
cognitive functional mechanisms that have not been sufficiently analyzed or defined by any
other methods.
Thus, under normal brain conditions, it was shown that (Figure 3, a):
1. Both the cholinergic projective systems and interneurons of the rat cortex and hippocam‐
pus are actively involved in learning and memory processes in the Morris water maze
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model [28]. The presynapses of cholinergic interneurons in the cat temporal associative
cortical area do not participate in inherited abilities for the analysis of images [25] but all
of other associative cortical areas (frontal and parietal) active participated in cognitive
processes [153].
2. The cholinergic system participates not only in the mechanisms of learning and working
memory, which has been repeatedly observed [151, 157-160], but also in the mechanisms
of long-term memory [28]. The involvement of cholinergic projective systems in the
mechanisms of long-term memory is usually denied [161-164] or has been discussed in
only a few studies [165-167].
3. Each form of memory has an individual cholinergic synaptic composition [28]. This
conclusion agrees with the results of investigations into cholinergic and monoaminergic
systems obtained in the Morris water maze and some other behavioral models [165,
168-170].
4. Cholinergic projective neurons and interneurons of the rat cortex and hippocampus can
have both positive and negative connections with cognitive functions [28]. Identical
results were obtained in all cat cortical areas except the temporal zone. Cholinergic
projections in the temporal area had only negative connections with inherited cognitive
functions. The number of cholinergic presynapses may be more than doubled in this brain
area of cats with weak cognitive abilities as compared with cats with strong abilities [25].
Negative connections with cognitive functions are not specific for only the cholinergic
system. In morphological research on hippocampal mossy fibers (glutamatergic) in the
rat and mouse brain, feedback was also found between the quantity of synapses which
mossy fibers create and learning [171].
Taken together, these data demonstrate that the cholinergic mechanisms of learning and
memory are more complex than is currently perceived.
Stress and pathological stimuli initiate a considerable reorganization of the normal cholinergic
synaptic connections in cognitive functions. As an illustration, it was revealed during chronic
2VO conditions in the Morris water maze models that [28] (Figure 3, b):
1. The majority of normal cholinergic connections are lost and new connections arise.
2. Cholinergic link was considerably reduced in mechanisms of cognitive functions and
proportion of negative connections increased.
3. In addition to reduction, the structural isolation of cholinergic links in cognitive functions
and performance takes place; cortical cholinergic influences are completely removed from
spatial contextual functions as are hippocampal influences from spatially cued functions.
In general, cholinergic synaptic influences disappear in some forms of cognition. It is clear that
the consequences of different exposures on the cholinergic composition of cognitive functions
are individual; however, the itemized consequences of 2VO are general for other stress stimuli
such as acute severe hypoxia (4.5% O2, Figure 3, c) [141, 156] and changes in season from warm
to cold [25] (Figure 4).
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It is logical to assume that the reduction in cholinergic links in cognitive mechanisms is a
consequence of the degeneration of cholinergic fibers. However, the reverse was actually
Abbreviations: 1s2(Contextual)/1s1 (Cued), the inherited abilities, the first non-casual attempt of making decision in
the task (respectively, the second/ the first trial in the first session, “s “ inclued in the abbreviations of the forms of
cognition); 1s3-4 (Contextual)/1s2-4 (Cued), the working memory (averaged from the following trials in the first ses‐
sion); 2s2-4 and 3s2-4, the learning (average of trials in the second and the third sessions respectively); 2s1 and 3s1,
the long-term memory (the first trials on the next days after the first and the second sessions of training respectively).
SM and Sp, subfractions of the synaptic membranes and the synaptoplasm, respectively, of the cortical light (CL) and
heavy synaptosomes (CH) and hippocampal light (HL) and heavy synaptosomes (HH).
Pyramids towards up indicate a positive correlation between behavioural performance and ChAT activity; inverted
pyramidы indicate a negative correlation between behavioural performance and ChAT activity. In the rat groups
n=4-7. Correlations between behavioural performance and ChAT activity are represented with only valid values and
with the Bonferroni correction (p<0.02-0.001).
Figure 3. Values of r-criterion by the Pearson’s test of behavioural performance and ChAT activity in rats in the Morris
water maze in the spatial contextual and the spatial cued behavioural models under control (a, sham operated rats),
ischaemic (b, 2VO operated rats) and one month after a single severe hypobaric hypoxia (c, sham operated rats) condi‐
tions.
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observed. As was noted above, activation of ChAT was detected in the majority of the synaptic
subfractions, and this may reflect cholinergic hyperfunction or synaptogenesis in the 2VO rat
brain [28]. Moreover, ChAT activity showed a five- to ten-fold increase in the winter as
compares with the summer in synaptic subfractions of both projection and interneurons in the
temporal [25] as well in other cat cortical areas [156]. No quantitative distinctions in ChAT
activity were found in the synaptic subfractions of the cortex and the hippocampus of rats in
a month after a single acute hypoxic stress [156].
Abbreviations: SM, Sp, CL, CH, the same abbreviations of the subfractions as on Figure 3.
As on Figure 3, the pyramids towards up indicate a positive correlation between behavioural performance and ChAT
activity; inverted pyramids indicate a negative correlation between behavioural performance and ChAT activity. In the
cat groups n=6-8. Correlations behavioural performance and ChAT activity are represented with only valid values and
with the Bonferroni correction (p<0.02-0.001).
Figure 4. Values of r-criterion by the Pearson's test of behavioural performance and ChAT activity in cats in the inherit‐
ed abilities of generalisation, abstracting and gnosis of images tested on the basis of the food reflex (memory) in the
summer (a) and winter (b).
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The new cholinergic connections with cognitive functions that arise after 2VO are not neces‐
sarily the consequence of degeneration or dysfunction in the presynapses of key cholinergic
populations, i.e. these new connections could arise for other, indirect reasons. Therefore, it was
assumed that noticeable weakening of cholinergic synaptic influences on cognitive processes
is a consequence of adaptation. It seems that the cholinergic synaptic components of the highest
brain structures, besides their participation in cognition, are necessary for the functions
connected with survival under stress conditions.
At the same time, some cognitive functions were not affected by cholinergic reduction after
2VO [28]. All the more the inherited cognitive processes are preserved with annual seasonal
cholinergic reorganization [25, 156]. From this, it was concluded that, during stress conditions,
other mediator systems replace the cholinergic system in cognitive processes.
At least four questions follow from these data:
1. In what nervous functions are the cholinergic neuronal populations of the cortex and the
hippocampus involved, both projective and intrinsic, for the maintenance of viability of
an organism? Is it a function of regulation of the regional blood vessels or some other
factor?
2. Why are cholinergic synaptic influences lost from cognitive mechanisms? Is it a negative
dependence between vital and cognitive functions or low resistance of this neuronal
population to stress conditions?
3. Is the structural isolation of cholinergic links in cognitive functions presumes a functional
disbalance between the cortex and hippocampus? Is it a consequence of loss of cholinergic
modulating influences?
4. What mediator systems mediate the execution of cognitive functions instead of the
cholinergic system?
The answers to these questions are important for the restoration, maintenance and regulation
of cognitive and vital brain functions under stress and pathological conditions.
9. Conclusion
The synapse is a unique and the most dynamic and labile structure specialized in the chemical
transmission of nerve signals, an inherent structure of the neuron only.
Cholinergic system is essential constituent of the mammalian brain. Due to research using the
synaptosomal and other synaptic fractions, knowledge behind the metabolism and secretory
function of ACh and some new notion concerning the cholinergic mechanisms of cognitive
functions under normal conditions and stress stimuli were gained. Today, however, accumu‐
lated data does not provide answers to the all questions as many more questions are asked.
We have tried to outline some of the outstanding problems in the course of presenting the
material.
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The experimental cell physiology began to develop after the invention of the microscope by
A. van Leeuwenhoek and his discoveries in the middle of the 17th century. Experimental
synaptology began to develop after the invention of the electron microscope in the 1930s by
M. Knoll and E. Ruska, ie three centuries later! Prior to this, researchers for the longest time,
following two great neurohistologists, S. Ramón y Cajal and C. Golgi, in general could not
reach a consensus, whether the brain is a cellular structure or syncytium? Only the electron
microscope proved that a synapse exists.
Thus the science of the synapse is very young neuroscience.
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